tekturna
novartis europharm ltd. - aliskiren - hypertension - agents acting on the renin-angiotensin system - treatment of essential hypertension
imprida hct
novartis europharm ltd. - amlodipine, valsartan, hydrochlorothiazide - hypertension - angiotensin ii antagonists, plain, angiotensin ii antagonists, combinations - treatment of essential hypertension as substitution therapy in adult patients whose blood pressure is adequately controlled on the combination of amlodipine, valsartan and hydrochlorothiazide (hct), taken either as three single-component formulations or as a dual-component and a single-component formulation.
enviage
novartis europharm ltd. - aliskiren - hypertension - agents acting on the renin-angiotensin system - treatment of essential hypertension
trazec
novartis europharm ltd. - nateglinide - diabetes mellitus, type 2 - drugs used in diabetes - nateglinide is indicated for combination therapy with metformin in type 2 diabetic patients inadequately controlled despite a maximally tolerated dose of metformin alone.
gel-malicid 200mg/100mg/5ml suspension
am-europharma corporation - aluminum hydoxide , magnesium hydroxide - suspension - 200mg/100mg/5ml
none 225mg/200mg suspension
am-europharma corporation - aluminum hydroxide , magnesium hydroxide - suspension - 225mg/200mg
none 100 mg/5ml syrup
am-europharma corp - carbocisteine - syrup - 100 mg/5ml
ameustyn 50mg/ml syrup (oral drops)
am-europharma corporation - carbocisteine - syrup (oral drops) - 50mg/ml
ameustyn 500 mg capsule
am-europharma corporation - carbocisteine - capsule - 500 mg
cecavil 125mg/ 5ml powder for suspension
am-europharma corporation - cefaclor (as monohydrate) - powder for suspension - 125mg/ 5ml